Rankings
▼
Calendar
DXR
Daxor Corporation
$57M
Q4 2012 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$1M
+87.3% YoY
Gross Profit
$1M
100.0% margin
Operating Income
$1M
87.7% margin
Net Income
$3M
250.3% margin
EPS (Diluted)
$0.72
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$10M
Stock-Based Comp.
$5,838
Balance Sheet
Total Assets
$56M
Total Liabilities
$21M
Stockholders' Equity
$35M
Cash & Equivalents
$0
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$638,711
+87.3%
Gross Profit
$1M
$312,456
+282.9%
Operating Income
$1M
-$3M
+136.3%
Net Income
$3M
-$4M
+183.4%
← FY 2012
All Quarters
Q2 2013 →
DXR Q4 2012 Earnings — Daxor Corporation Revenue & Financial Results | Market Cap Arena